NASDAQ:APYX Apyx Medical (APYX) Stock Price, News & Analysis → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free APYX Stock Alerts $1.41 -0.01 (-0.70%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$1.41▼$1.4950-Day Range$1.25▼$2.2452-Week Range$1.21▼$7.97Volume13,325 shsAverage Volume67,024 shsMarket Capitalization$48.84 millionP/E RatioN/ADividend YieldN/APrice Target$6.17 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Apyx Medical alerts: Email Address Apyx Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside337.4% Upside$6.17 Price TargetShort InterestHealthy1.31% of Float Sold ShortDividend StrengthN/ASustainability-1.07Upright™ Environmental ScoreNews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.74) to ($0.58) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.07 out of 5 starsMedical Sector166th out of 904 stocksSurgical & Medical Instruments Industry25th out of 96 stocks 3.5 Analyst's Opinion Consensus RatingApyx Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageApyx Medical has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.31% of the float of Apyx Medical has been sold short.Short Interest Ratio / Days to CoverApyx Medical has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Apyx Medical has recently decreased by 47.49%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldApyx Medical does not currently pay a dividend.Dividend GrowthApyx Medical does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreApyx Medical has received a 60.75% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Electrosurgical devices" product. See details.Environmental SustainabilityThe Environmental Impact score for Apyx Medical is -1.07. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Apyx Medical this week, compared to 2 articles on an average week. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Apyx Medical insiders have not sold or bought any company stock.Percentage Held by Insiders13.10% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions55.33% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Apyx Medical are expected to grow in the coming year, from ($0.74) to ($0.58) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Apyx Medical is -2.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Apyx Medical is -2.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApyx Medical has a P/B Ratio of 1.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Apyx Medical Stock (NASDAQ:APYX)Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. Its Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also develops and manufactures hand pieces for open and laparoscopic procedures; and OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Read More APYX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APYX Stock News HeadlinesMay 2, 2024 | americanbankingnews.comApyx Medical (APYX) Set to Announce Earnings on ThursdayApril 25, 2024 | finance.yahoo.comApyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024May 5, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...April 22, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Lifestance Health Group (LFST), LifeMD (LFMD)April 21, 2024 | finance.yahoo.comApyx Medical Corporation (APYX)April 17, 2024 | finance.yahoo.comOcean Drive Plastic Surgery Founder Dr. Alan Durkin Appointed VIO Med Spa Chief Medical OfficerApril 11, 2024 | finance.yahoo.comApyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ SummitApril 11, 2024 | businesswire.comApyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' SummitMay 5, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...March 26, 2024 | finance.yahoo.comDowngrade: Here's How Analysts See Apyx Medical Corporation (NASDAQ:APYX) Performing In The Near TermMarch 23, 2024 | seekingalpha.comApyx Medical Corporation (APYX) Q4 2023 Earnings Call TranscriptMarch 23, 2024 | finance.yahoo.comApyx Medical Corporation (NASDAQ:APYX) Just Reported And Analysts Have Been Cutting Their EstimatesMarch 22, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and OKYO Pharma Limited Sponsored ADR (OKYO)March 22, 2024 | finance.yahoo.comApyx Medical Corporation (NASDAQ:APYX) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | finance.yahoo.comFurther weakness as Apyx Medical (NASDAQ:APYX) drops 22% this week, taking three-year losses to 87%March 22, 2024 | markets.businessinsider.comApyx Medical (APYX) Receives a Hold from JMP SecuritiesMarch 21, 2024 | finance.yahoo.comQ4 2023 Apyx Medical Corp Earnings CallMarch 21, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: OmniAb (OABI) and Apyx Medical (APYX)March 21, 2024 | investorplace.comAPYX Stock Earnings: Apyx Medical Misses EPS, Misses Revenue for Q4 2023March 21, 2024 | msn.comApyx Medical reports mixed Q4 results; initiates FY24 outlookMarch 21, 2024 | washingtonpost.comApyx: Q4 Earnings SnapshotMarch 21, 2024 | businesswire.comApyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial OutlookMarch 16, 2024 | finance.yahoo.comAPYX Apr 2024 5.000 putMarch 4, 2024 | businesswire.comApyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024March 4, 2024 | businesswire.comApyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024February 27, 2024 | markets.businessinsider.comCraig-Hallum Gives a Buy Rating to Codexis (CDXS)February 21, 2024 | finance.yahoo.comApyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific MeetingSee More Headlines Receive APYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/21/2024Today5/05/2024Next Earnings (Confirmed)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:APYX CUSIPN/A CIK719135 Webwww.apyxmedical.com Phone(727) 384-2323Fax800-323-1640Employees252Year FoundedN/APrice Target and Rating Average Stock Price Target$6.17 High Stock Price Target$9.00 Low Stock Price Target$4.50 Potential Upside/Downside+337.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.54) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,710,000.00 Net Margins-35.75% Pretax Margin-40.65% Return on Equity-54.90% Return on Assets-28.41% Debt Debt-to-Equity Ratio1.23 Current Ratio5.52 Quick Ratio4.74 Sales & Book Value Annual Sales$52.35 million Price / Sales0.93 Cash FlowN/A Price / Cash FlowN/A Book Value$0.78 per share Price / Book1.81Miscellaneous Outstanding Shares34,640,000Free Float30,106,000Market Cap$48.84 million OptionableOptionable Beta1.10 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Charles D. Goodwin II (Age 57)President, CEO & Director Comp: $813.13kMr. Matthew C. Hill CPA (Age 55)CFO, Treasurer & Secretary Comp: $445.95kMr. Moshe Citronowicz (Age 71)Senior Vice President Comp: $405.47kMr. Todd Hornsby (Age 47)Executive Vice President Comp: $561.77kKey CompetitorsHealth Sciences Acquisitions Co. 2NASDAQ:HSAQDaxorNASDAQ:DXRInspireMDNYSE:NSPRIceCure MedicalNASDAQ:ICCMCytosorbentsNASDAQ:CTSOView All CompetitorsInsiders & InstitutionsCommonwealth Equity Services LLCBought 497,080 shares on 4/30/2024Ownership: 1.435%Silverberg Bernstein Capital Management LLCBought 7,507 shares on 4/11/2024Ownership: 1.794%Greenwood Capital Associates LLCSold 9,385 shares on 3/5/2024Ownership: 0.844%RTW Investments LPSold 751,231 shares on 2/14/2024Ownership: 2.962%Pura Vida Investments LLCSold 756,990 shares on 2/13/2024Ownership: 0.231%View All Insider TransactionsView All Institutional Transactions APYX Stock Analysis - Frequently Asked Questions Should I buy or sell Apyx Medical stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" APYX shares. View APYX analyst ratings or view top-rated stocks. What is Apyx Medical's stock price target for 2024? 2 Wall Street research analysts have issued twelve-month price targets for Apyx Medical's stock. Their APYX share price targets range from $4.50 to $9.00. On average, they anticipate the company's share price to reach $6.17 in the next twelve months. This suggests a possible upside of 337.4% from the stock's current price. View analysts price targets for APYX or view top-rated stocks among Wall Street analysts. How have APYX shares performed in 2024? Apyx Medical's stock was trading at $2.62 at the start of the year. Since then, APYX shares have decreased by 46.2% and is now trading at $1.41. View the best growth stocks for 2024 here. Are investors shorting Apyx Medical? Apyx Medical saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 371,100 shares, a decline of 47.5% from the March 31st total of 706,700 shares. Based on an average daily volume of 154,700 shares, the days-to-cover ratio is currently 2.4 days. Approximately 1.3% of the company's shares are short sold. View Apyx Medical's Short Interest. When is Apyx Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our APYX earnings forecast. How can I listen to Apyx Medical's earnings call? Apyx Medical will be holding an earnings conference call on Thursday, May 9th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415 with passcode "13745889". How were Apyx Medical's earnings last quarter? Apyx Medical Co. (NASDAQ:APYX) posted its quarterly earnings data on Thursday, March, 21st. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.06. The firm earned $14.66 million during the quarter, compared to analyst estimates of $14.40 million. Apyx Medical had a negative net margin of 35.75% and a negative trailing twelve-month return on equity of 54.90%. What guidance has Apyx Medical issued on next quarter's earnings? Apyx Medical issued an update on its FY 2024 earnings guidance on Thursday, March, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $49.7 million-$52.9 million, compared to the consensus revenue estimate of $59.8 million. What other stocks do shareholders of Apyx Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), Procter & Gamble (PG), STORE Capital (STOR), Wells Fargo & Company (WFC), Boeing (BA), Bank of America (BAC) and Delta Air Lines (DAL). Who are Apyx Medical's major shareholders? Apyx Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Silverberg Bernstein Capital Management LLC (1.79%), Commonwealth Equity Services LLC (1.43%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Charles D Goodwin II, Matthew C Hill and Todd Hornsby. View institutional ownership trends. How do I buy shares of Apyx Medical? Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:APYX) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCThe asset beating inflation by 4xColonial MetalsCharles Payne Demystifies OptionsUnstoppable ProsperityThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apyx Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
